Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Despite being only recently coined in 2023, CKM syndrome exposes the widespread and interconnected nature of heart, kidney, and metabolic diseases, prompting a shift towards early detection and integrated treatment strategies. Susan Gilchrist, a preventive cardiologist and epidemiologist at the…
High morning blood sugar levels can be a natural part of the dawn phenomenon, caused by hormonal shifts that may affect people with diabetes differently. Recognising these patterns is crucial for effective management and avoiding unnecessary concern. It can be…
A new subscription service from Diabetes Meal Plans offers personalised weekly menus featuring nutritious, blood sugar-friendly recipes designed to support type 2 diabetes management, with added resources and community support to encourage long-term healthy eating. A new weekly meal plan…
Clinicians are exploring the potential for lower and less frequent doses of GLP-1 receptor agonists to maintain weight-loss benefits, amidst cautious optimism and limited but promising evidence for practice-changing protocols. Clinicians are increasingly looking beyond the familiar weight-loss narrative surrounding…
Emerging research emphasises the importance of routine screening and lifestyle management to prevent serious complications associated with gestational diabetes, as new trends challenge traditional approaches. Gestational diabetes is one of the health issues that can emerge during pregnancy and, if…
Researchers at USC discover a tiny mitochondrial microprotein, MENTSH, that may shed light on genetic vulnerabilities in type 2 diabetes, offering potential new avenues for targeted treatments. Researchers at the University of Southern California have identified a tiny mitochondrial microprotein…
The American Diabetes Association faces renewed scrutiny over its clinical guidelines, with critics warning that its emphasis on expensive drug therapies like Ozempic and Wegovy risks widening health disparities and sidelining preventive care strategies. The American Diabetes Association is under…
The rise of continuous glucose monitors among non-diabetics, driven by social media and biohacking, sparks both curiosity and caution among health experts over their accuracy, benefits, and potential psychological impact. Continuous glucose monitors, once a largely clinical tool for people…
Advances in continuous glucose monitoring technology are expanding beyond insulin users, offering new insights for type 2 diabetes management and health optimisation, but require effective patient education and awareness of potential drawbacks. Continuous glucose monitoring is increasingly being positioned as…
Patients often face sudden increases in insulin costs, not from coverage changes, but due to complex formulary revisions and rebate arrangements overseen by pharmacy benefit managers, highlighting opaque drug pricing practices. Many people are startled when the price of insulin…
A recent study reveals genetically engineered donor islet cells functioning 14 months post-transplant without immunosuppressants, marking a significant step towards a potential cure for type 1 diabetes amidst ongoing technological and ethical debates. Recent developments in diabetes care are pointing…
Recent advances in drug development are shifting the landscape of type 1 diabetes from symptomatic management to disease modification and potential insulin independence, driven by novel therapies like Sanofi’s Tzield and emerging cell-based approaches. Type 1 diabetes research is moving…
